Developer docs
API playgroundTry for free, no card

Search company profiles

nordvacc

Full company profile

uuid02m7tyf

Namestring
nordvacc
Websiteurl
nordvacc.se
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Nordvacc is a Swedish private company founded in 1983 that markets and distributes veterinary vaccines and pharmaceuticals for both companion animals and farm animals. The company's website is nordvacc.se, indicating a Nordic market orientation. Its business model centers on the wholesale distribution of biological and pharmaceutical products to veterinary practitioners, livestock producers, and other animal health customers, a segment that requires GDP-compliant cold-chain logistics, manufacturer supply agreements, and regulatory product registrations.

The input data provides no further detail on Nordvacc's product portfolio, supplier relationships, headcount, pricing structure, geographic footprint beyond the Nordics, customer mix, or financial performance. The company website returned only a CAPTCHA verification page during data collection, precluding extraction of detailed operational information. No information is available regarding ownership structure, parent company affiliation, funding history, or recent strategic actions.

As a four-decade-old veterinary distribution specialist, Nordvacc likely operates as a niche incumbent in the Nordic animal health market, but the depth of its competitive position, scale, and growth trajectory cannot be assessed from the available data.

Short descriptiontext

Nordvacc is a Swedish veterinary distributor founded in 1983 that markets and distributes vaccines and pharmaceuticals for companion and farm animals across the Nordic region, serving veterinary practitioners and livestock producers.

Ownership categoryenum
akta.pro rankint
Markets served

Serves global market

Keyword5 values
veterinary vaccines, animal pharmaceuticals, livestock health products, companion animal medicines, veterinary distribution
Industry4 codes
1Veterinary Pharmaceutical Wholesalers & Distributors
CodeHLAMAIAAPrimaryYes
2Veterinary Vaccine & Biologics Distributors
CodeHLAMAIACPrimaryNo
3Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns)
CodeHLAMAIAGPrimaryNo
4Veterinary Vaccines (Biologics)
CodeHLAMAEALPrimaryNo
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Pharmaceuticals Distribution
No data
Cost components4 values
Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Nordvacc markets and distributes veterinary vaccines and pharmaceutical products for companion animals and farm animals. The company operates as a specialized animal-health distributor serving the Nordic market, sourcing veterinary medicines from manufacturers and making them available to veterinary professionals and animal owners/producers.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeDirect peer
Description

Spain-based animal-health company specializing in veterinary vaccines for livestock and aquaculture, with growing companion-animal presence. Comparable as a European vaccine specialist whose distribution strategy in the Nordics would directly affect Nordvacc's competitive position.

TypeBroad incumbent
Description

Largest global animal-health manufacturer with broad veterinary vaccine and pharmaceutical portfolios across companion and livestock species. Highly comparable because it competes for the same veterinary clinic customers Nordvacc serves and increasingly pursues direct distribution in mature European markets.

TypeDirect peer
Description

German veterinary vaccines and biologics manufacturer with a focus on livestock and zoonotic disease vaccines. Comparable as both a potential upstream supplier to Nordvacc and a competitor in regional European vaccine distribution markets.

TypeBroad incumbent
Description

Global animal-health manufacturer with companion-animal and livestock vaccines and therapeutics. Comparable as both a potential principal supplier and a competitor pursuing direct distribution channels in European veterinary markets.

TypeBroad incumbent
Description

Global veterinary pharmaceutical company headquartered in France, offering vaccines, parasiticides, and therapeutics primarily for companion animals. Comparable because it addresses the same European veterinary clinic customers and competes for Nordic vaccine share.

TypeBroad incumbent
Description

UK-based specialist veterinary pharmaceuticals company focused on companion-animal therapeutics and endocrinology. Comparable as a competing supplier of veterinary pharmaceuticals into European veterinary practices, potentially complementing or substituting Nordvacc's product lines.

TypeBroad incumbent
Description

France-headquartered global animal-health company with a strong focus on veterinary vaccines and pharmaceuticals across companion and livestock species. Comparable as a European regional heavyweight whose products and distribution strategies directly overlap with Nordvacc's footprint.

TypeBroad incumbent
Description

European-headquartered veterinary pharmaceutical company focused on companion animals and livestock. Comparable as a mid-sized European animal-health player that competes in similar Nordic distribution channels and product categories.

TypeBroad incumbent
Description

Animal-health division of Merck offering vaccines, parasiticides, and pharmaceuticals across companion and farm animals. Directly comparable as a principal whose products Nordvacc distributes and which could choose to bypass regional distributors in the Nordics.

TypeBroad incumbent
Description

Major animal-health manufacturer with a strong veterinary vaccines franchise, particularly for swine and companion animals. Comparable because its biologics portfolio is a likely core of Nordvacc's distributed inventory and it competes for the same Nordic veterinary practice customers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

nordvacc

Veterinary Pharmaceuticals Distributionnordvacc.se

Nordvacc is a Swedish veterinary distributor founded in 1983 that markets and distributes vaccines and pharmaceuticals for companion and farm animals across the Nordic region, serving veterinary practitioners and livestock producers.

What nordvacc does

Nordvacc is a Swedish private company founded in 1983 that markets and distributes veterinary vaccines and pharmaceuticals for both companion animals and farm animals. The company's website is nordvacc.se, indicating a Nordic market orientation. Its business model centers on the wholesale distribution of biological and pharmaceutical products to veterinary practitioners, livestock producers, and other animal health customers, a segment that requires GDP-compliant cold-chain logistics, manufacturer supply agreements, and regulatory product registrations.

The input data provides no further detail on Nordvacc's product portfolio, supplier relationships, headcount, pricing structure, geographic footprint beyond the Nordics, customer mix, or financial performance. The company website returned only a CAPTCHA verification page during data collection, precluding extraction of detailed operational information. No information is available regarding ownership structure, parent company affiliation, funding history, or recent strategic actions.

As a four-decade-old veterinary distribution specialist, Nordvacc likely operates as a niche incumbent in the Nordic animal health market, but the depth of its competitive position, scale, and growth trajectory cannot be assessed from the available data.

nordvacc firmographics

Firmographics
Name
nordvacc
Website
https://nordvacc.se
Company type
Private
Founded year
1983
Short description
Nordvacc is a Swedish veterinary distributor founded in 1983 that markets and distributes vaccines and pharmaceuticals for companion and farm animals across the Nordic region, serving veterinary practitioners and livestock producers.
Ownership category
akta.pro rank

nordvacc industry classification

Industry
Product category
Veterinary Pharmaceuticals Distribution
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)
akta.pro secondary industries
Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns) (HLAMAIAG), Veterinary Vaccines (Biologics) (HLAMAEAL)

Keywords

  • Veterinary vaccines
  • Animal pharmaceuticals
  • Livestock health products
  • Companion animal medicines
  • Veterinary distribution

nordvacc business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales

nordvacc product offering

Product offering

Core offering

Nordvacc markets and distributes veterinary vaccines and pharmaceutical products for companion animals and farm animals. The company operates as a specialized animal-health distributor serving the Nordic market, sourcing veterinary medicines from manufacturers and making them available to veterinary professionals and animal owners/producers.

Differentiator

Problem solved

Functional benefit

Companies that use nordvacc

Customer profile

Ideal customer profiles2 records

nordvacc technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

nordvacc competitors and assessment

Company assessment

Direct peers

  • HIPRA: Spain-based animal-health company specializing in veterinary vaccines for livestock and aquaculture, with growing companion-animal presence. Comparable as a European vaccine specialist whose distribution strategy in the Nordics would directly affect Nordvacc's competitive position.
  • IDT Biologika: German veterinary vaccines and biologics manufacturer with a focus on livestock and zoonotic disease vaccines. Comparable as both a potential upstream supplier to Nordvacc and a competitor in regional European vaccine distribution markets.

Broad incumbents

  • Zoetis: Largest global animal-health manufacturer with broad veterinary vaccine and pharmaceutical portfolios across companion and livestock species. Highly comparable because it competes for the same veterinary clinic customers Nordvacc serves and increasingly pursues direct distribution in mature European markets.
  • Elanco Animal Health: Global animal-health manufacturer with companion-animal and livestock vaccines and therapeutics. Comparable as both a potential principal supplier and a competitor pursuing direct distribution channels in European veterinary markets.
  • Virbac: Global veterinary pharmaceutical company headquartered in France, offering vaccines, parasiticides, and therapeutics primarily for companion animals. Comparable because it addresses the same European veterinary clinic customers and competes for Nordic vaccine share.
  • Dechra Pharmaceuticals: UK-based specialist veterinary pharmaceuticals company focused on companion-animal therapeutics and endocrinology. Comparable as a competing supplier of veterinary pharmaceuticals into European veterinary practices, potentially complementing or substituting Nordvacc's product lines.
  • Ceva Santé Animale: France-headquartered global animal-health company with a strong focus on veterinary vaccines and pharmaceuticals across companion and livestock species. Comparable as a European regional heavyweight whose products and distribution strategies directly overlap with Nordvacc's footprint.
  • Vetoquinol: European-headquartered veterinary pharmaceutical company focused on companion animals and livestock. Comparable as a mid-sized European animal-health player that competes in similar Nordic distribution channels and product categories.
  • MSD Animal Health: Animal-health division of Merck offering vaccines, parasiticides, and pharmaceuticals across companion and farm animals. Directly comparable as a principal whose products Nordvacc distributes and which could choose to bypass regional distributors in the Nordics.
  • Boehringer Ingelheim Animal Health: Major animal-health manufacturer with a strong veterinary vaccines franchise, particularly for swine and companion animals. Comparable because its biologics portfolio is a likely core of Nordvacc's distributed inventory and it competes for the same Nordic veterinary practice customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

nordvacc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

nordvacc leadership team

Management profile

Number of profiles

nordvacc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

nordvacc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about nordvacc

What does nordvacc do?

Nordvacc markets and distributes veterinary vaccines and pharmaceutical products for companion animals and farm animals. The company operates as a specialized animal-health distributor serving the Nordic market, sourcing veterinary medicines from manufacturers and making them available to veterinary professionals and animal owners/producers.

When was nordvacc founded?

nordvacc was founded in 1983.

Who are nordvacc's main competitors?

Direct peers on record are HIPRA and IDT Biologika. Broad incumbents are Zoetis, Elanco Animal Health, Virbac, Dechra Pharmaceuticals, Ceva Santé Animale, Vetoquinol, MSD Animal Health and Boehringer Ingelheim Animal Health.

Does nordvacc have an API?

No public API is recorded for nordvacc.

What industry is nordvacc in?

nordvacc's product category is Veterinary Pharmaceuticals Distribution. Its primary akta.pro industry code is HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors, with a secondary code of HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales